Cargando…

Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice

BACKGROUND: Clinical studies demonstrate that the N-methyl-D-aspartate (NMDA) receptor antagonist, ketamine, induces rapid antidepressant effects in patients with refractive major depressive disorder and bipolar depression. This rapid onset of action makes ketamine a highly attractive drug for patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Xian-Cang, Dang, Yong-Hui, Jia, Min, Ma, Rui, Wang, Fen, Wu, Jin, Gao, Cheng-Ge, Hashimoto, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563541/ https://www.ncbi.nlm.nih.gov/pubmed/23390559 http://dx.doi.org/10.1371/journal.pone.0056053

Ejemplares similares

Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
por: Zhang, Jing, et al.
Publicado: (2020)

Glycogen Synthase Kinase 3 (GSK3) Inhibitor, SB-216763, Promotes Pluripotency in Mouse Embryonic Stem Cells
por: Kirby, Leslie A., et al.
Publicado: (2012)

Corrigendum: Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
Publicado: (2021)

Lenticular mitoprotection. Part A: Monitoring mitochondrial depolarization with JC-1 and artifactual fluorescence by the glycogen synthase kinase-3β inhibitor, SB216763
por: Brooks, Morgan M., et al.
Publicado: (2013)

Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties
por: Zunszain, P A, et al.
Publicado: (2013)

Small-Molecule SB216763-Loaded Microspheres Repair Peripheral Nerve Injury in Small Gap Tubulization
por: Rao, Feng, et al.
Publicado: (2019)

Testing Fmr1(KO) Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127
por: Westmark, Pamela R., et al.
Publicado: (2021)

A BDNF Val66Met Polymorphism and Ketamine-induced Rapid Antidepressant Action
por: Hashimoto, Kenji
Publicado: (2012)

SB‐216763, a GSK‐3β inhibitor, protects against aldosterone‐induced cardiac, and renal injury by activating autophagy
por: Zhang, Yi‐De, et al.
Publicado: (2018)

Role of Inflammatory Bone Markers in the Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model
por: Zhang, Kai, et al.
Publicado: (2018)

Enhancement of Glycosaminoglycan-Rich Matrix Production in Human Marrow-Derived Mesenchymal Stem Cell Chondrogenic Culture by Lithium Chloride and SB216763 Treatment
por: Baghaban Eslaminejad, Mohamadreza, et al.
Publicado: (2011)

PM(2.5) Exposure-Linked Mitochondrial Dysfunction Negates SB216763-Mediated Cardio-Protection against Myocardial Ischemia–Reperfusion Injury
por: Sivakumar, Bhavana, et al.
Publicado: (2023)

Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model
por: Zhang, Kai, et al.
Publicado: (2018)

No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model
por: Chang, Lijia, et al.
Publicado: (2018)

Author Correction: Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model
por: Zhang, Kai, et al.
Publicado: (2018)

Social Isolation-Induced Aggression Potentiates Anxiety and Depressive-Like Behavior in Male Mice Subjected to Unpredictable Chronic Mild Stress
por: Ma, Xian-cang, et al.
Publicado: (2011)

5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model
por: Zhang, Kai, et al.
Publicado: (2017)

Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
por: Yang, Chun, et al.
Publicado: (2019)

PKA-CREB-BDNF signaling regulated long lasting antidepressant activities of Yueju but not ketamine
por: Xue, Wenda, et al.
Publicado: (2016)

Sustained release of a highly specific GSK3β inhibitor SB216763 in the PCL scaffold creates an osteogenic niche for osteogenesis, anti-adipogenesis, and potential angiogenesis
por: Gong, Weimin, et al.
Publicado: (2023)

Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression
por: Yang, Bangkun, et al.
Publicado: (2016)

Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
por: Yao, Wei, et al.
Publicado: (2021)

Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
por: Hashimoto, Kenji
Publicado: (2019)

Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model
por: Sun, H-L, et al.
Publicado: (2016)

Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
por: Zhang, Kai, et al.
Publicado: (2020)

Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
por: Yao, Wei, et al.
Publicado: (2021)

Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
por: Dong, Chao, et al.
Publicado: (2016)

NMDAR inhibition-independent antidepressant actions of ketamine metabolites
por: Zanos, Panos, et al.
Publicado: (2016)

Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
por: Yang, Chun, et al.
Publicado: (2017)

Ketamine: stimulating antidepressant treatment?
por: Malhi, Gin S., et al.
Publicado: (2016)

Immunoregulation and antidepressant effect of ketamine
por: Zhang, Nan, et al.
Publicado: (2021)

Regulation of Tau Protein on the Antidepressant Effects of Ketamine in the Chronic Unpredictable Mild Stress Model
por: Wen, Gehua, et al.
Publicado: (2019)

Antidepressant Effects of Ketamine on Depression-like Behavior in Juvenile Mice after Neonatal Dexamethasone Exposure
por: Li, Su-Xia, et al.
Publicado: (2014)

Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)

Rapid and long-lasting antidepressant-like effects of ketamine and their relationship with the expression of brain enzymes, BDNF, and astrocytes
por: Viana, G.S.B., et al.
Publicado: (2020)

Control of Glycogen Content in Retina: Allosteric Regulation of Glycogen Synthase
por: Osorio-Paz, Ixchel, et al.
Publicado: (2012)

A synaptic locus for TrkB signaling underlying ketamine rapid antidepressant action
por: Lin, Pei-Yi, et al.
Publicado: (2021)

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
por: Yang, C, et al.
Publicado: (2015)

Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine’s Antidepressant Action
por: Aleksandrova, Lily R., et al.
Publicado: (2017)

Opioid Properties of Nitrous Oxide and Ketamine Contribute to Their Antidepressant Actions
por: Gillman, Mark A
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_99cm5ffbrbfqq61odgi62du2ee